Neoadjuvant chemoradiotherapy improves survival in locally advanced esophageal squamous cell carcinoma

COPENHAGEN, Denmark â€” The addition of neoadjuvant chemoradiotherapy to surgery extended OS in patients with locally advanced esophageal squamous cell carcinoma, according to phase 3 study results presented at the European Society for Medical Oncology Congress.
http://www.healio.com/hematology-oncology/gastrointestinal-cancer/news/online/%7Bf925ffbe-775f-4f19-9b42-09b9eb6ac2f6%7D/neoadjuvant-chemoradiotherapy-improves-survival-in-locally-advanced-esophageal-squamous-cell-carcinoma

AUDIENCES

SUBJECTS

Post Surgical

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino